News
Year 2024 Highlights
19.12.2024
Advancement in product development, accelerated market entry and exhibitions: In 2024, Uniogen experienced an exceptional year marked by significant progress…
Read more
Uniogen´s Ovarian Cancer test now a part of AMPlify program
1.10.2024
In August the company was accepted into the AMPlify program (an accelerated market entry platform), which is organized in collaboration…
Read more
Meet our Oncology Clinical Manager Kaisa Huhtinen
9.9.2024
Kaisa Huhtinen, Uniogen´s Oncology Clinical Manager, has a deep understanding of ovarian cancer diagnostics as a PhD and an Associate…
Read more
Uniogen featured in Yle, the Finnish Broadcasting Company, news
8.3.2024
Uniogen has been featured in Finland’s national public broadcasting company news for developing a blood test that could significantly speed…
Read more
Explore the science behind breakthroughs: a list of publications of our advanced cancer diagnostic platform now available
29.2.2024
Uniogen’s cancer diagnostic platform is based on research conducted and published at the University of Turku. Studies show that the…
Read more
Uniogen receives prestigious Seal Of Excellence from EIC for innovative cancer diagnostics solution
19.12.2023
Uniogen has achieved a remarkable milestone by receiving the esteemed Seal of Excellence from the European Innovation Council (EIC). This…
Read more
Early diagnosis of ovarian cancer shows promise with Uniogen’s test
2.11.2023
Detecting ovarian cancer early has always been challenging, but Uniogen’s test under development, is changing that. Dive in to see…
Read more
Press release: Finnish diagnostics company Uniogen is developing a test for timely detection of ovarian cancer
2.3.2023
Specialised in the diagnostics of infectious and cancer diseases, Uniogen is currently developing, among other things, a test for detecting…
Read more